492 related articles for article (PubMed ID: 15557131)
1. Hydrocortisone infusion for severe community-acquired pneumonia: a preliminary randomized study.
Confalonieri M; Urbino R; Potena A; Piattella M; Parigi P; Puccio G; Della Porta R; Giorgio C; Blasi F; Umberger R; Meduri GU
Am J Respir Crit Care Med; 2005 Feb; 171(3):242-8. PubMed ID: 15557131
[TBL] [Abstract][Full Text] [Related]
2. Hydrocortisone plus fludrocortisone for community acquired pneumonia-related septic shock: a subgroup analysis of the APROCCHSS phase 3 randomised trial.
Heming N; Renault A; Kuperminc E; Brun-Buisson C; Megarbane B; Quenot JP; Siami S; Cariou A; Forceville X; Schwebel C; Leone M; Timsit JF; Misset B; Benali MA; Colin G; Souweine B; Asehnoune K; Mercier E; Chimot L; Charpentier C; François B; Boulain T; Petitpas F; Constantin JM; Dhonneur G; Baudin F; Combes A; Bohé J; Loriferne JF; Cook F; Slama M; Leroy O; Capellier G; Dargent A; Hissem T; Bounab R; Maxime V; Moine P; Bellissant E; Annane D; ;
Lancet Respir Med; 2024 May; 12(5):366-374. PubMed ID: 38310918
[TBL] [Abstract][Full Text] [Related]
3. Stress doses of hydrocortisone reverse hyperdynamic septic shock: a prospective, randomized, double-blind, single-center study.
Briegel J; Forst H; Haller M; Schelling G; Kilger E; Kuprat G; Hemmer B; Hummel T; Lenhart A; Heyduck M; Stoll C; Peter K
Crit Care Med; 1999 Apr; 27(4):723-32. PubMed ID: 10321661
[TBL] [Abstract][Full Text] [Related]
4. [Prolonged infusion of hydrocortisone in patients with severe community acquired pneumonia].
Confalonieri M; Trevisan R
Recenti Prog Med; 2006 Jan; 97(1):32-6. PubMed ID: 16535928
[TBL] [Abstract][Full Text] [Related]
5. Effect of stress doses of hydrocortisone on S-100B vs. interleukin-8 and polymorphonuclear elastase levels in human septic shock.
Mussack T; Briegel J; Schelling G; Biberthaler P; Jochum M
Clin Chem Lab Med; 2005; 43(3):259-68. PubMed ID: 15843228
[TBL] [Abstract][Full Text] [Related]
6. Hydrocortisone infusion for severe community-acquired pneumonia: the role of relative adrenal insufficiency.
Jalloul A
Am J Respir Crit Care Med; 2005 Sep; 172(6):781; author reply 782-3. PubMed ID: 16148196
[No Abstract] [Full Text] [Related]
7. Hydrocortisone in Severe Community-Acquired Pneumonia.
Dequin PF; Meziani F; Quenot JP; Kamel T; Ricard JD; Badie J; Reignier J; Heming N; Plantefève G; Souweine B; Voiriot G; Colin G; Frat JP; Mira JP; Barbarot N; François B; Louis G; Gibot S; Guitton C; Giacardi C; Hraiech S; Vimeux S; L'Her E; Faure H; Herbrecht JE; Bouisse C; Joret A; Terzi N; Gacouin A; Quentin C; Jourdain M; Leclerc M; Coffre C; Bourgoin H; Lengellé C; Caille-Fénérol C; Giraudeau B; Le Gouge A;
N Engl J Med; 2023 May; 388(21):1931-1941. PubMed ID: 36942789
[TBL] [Abstract][Full Text] [Related]
8. Effect of corticosteroids on treatment failure among hospitalized patients with severe community-acquired pneumonia and high inflammatory response: a randomized clinical trial.
Torres A; Sibila O; Ferrer M; Polverino E; Menendez R; Mensa J; Gabarrús A; Sellarés J; Restrepo MI; Anzueto A; Niederman MS; Agustí C
JAMA; 2015 Feb; 313(7):677-86. PubMed ID: 25688779
[TBL] [Abstract][Full Text] [Related]
9. Dexamethasone and length of hospital stay in patients with community-acquired pneumonia: a randomised, double-blind, placebo-controlled trial.
Meijvis SC; Hardeman H; Remmelts HH; Heijligenberg R; Rijkers GT; van Velzen-Blad H; Voorn GP; van de Garde EM; Endeman H; Grutters JC; Bos WJ; Biesma DH
Lancet; 2011 Jun; 377(9782):2023-30. PubMed ID: 21636122
[TBL] [Abstract][Full Text] [Related]
10. Effect of Hydrocortisone on Development of Shock Among Patients With Severe Sepsis: The HYPRESS Randomized Clinical Trial.
Keh D; Trips E; Marx G; Wirtz SP; Abduljawwad E; Bercker S; Bogatsch H; Briegel J; Engel C; Gerlach H; Goldmann A; Kuhn SO; Hüter L; Meier-Hellmann A; Nierhaus A; Kluge S; Lehmke J; Loeffler M; Oppert M; Resener K; Schädler D; Schuerholz T; Simon P; Weiler N; Weyland A; Reinhart K; Brunkhorst FM;
JAMA; 2016 Nov; 316(17):1775-1785. PubMed ID: 27695824
[TBL] [Abstract][Full Text] [Related]
11. Time course of organ failure in patients with septic shock treated with hydrocortisone: results of the Corticus study.
Moreno R; Sprung CL; Annane D; Chevret S; Briegel J; Keh D; Singer M; Weiss YG; Payen D; Cuthbertson BH; Vincent JL
Intensive Care Med; 2011 Nov; 37(11):1765-72. PubMed ID: 21847649
[TBL] [Abstract][Full Text] [Related]
12. Adjunctive Glucocorticoid Therapy in Patients with Septic Shock.
Venkatesh B; Finfer S; Cohen J; Rajbhandari D; Arabi Y; Bellomo R; Billot L; Correa M; Glass P; Harward M; Joyce C; Li Q; McArthur C; Perner A; Rhodes A; Thompson K; Webb S; Myburgh J;
N Engl J Med; 2018 Mar; 378(9):797-808. PubMed ID: 29347874
[TBL] [Abstract][Full Text] [Related]
13. CAL02, a novel antitoxin liposomal agent, in severe pneumococcal pneumonia: a first-in-human, double-blind, placebo-controlled, randomised trial.
Laterre PF; Colin G; Dequin PF; Dugernier T; Boulain T; Azeredo da Silveira S; Lajaunias F; Perez A; François B
Lancet Infect Dis; 2019 Jun; 19(6):620-630. PubMed ID: 31056427
[TBL] [Abstract][Full Text] [Related]
14. Corticosteroid treatment and intensive insulin therapy for septic shock in adults: a randomized controlled trial.
; Annane D; Cariou A; Maxime V; Azoulay E; D'honneur G; Timsit JF; Cohen Y; Wolf M; Fartoukh M; Adrie C; Santré C; Bollaert PE; Mathonet A; Amathieu R; Tabah A; Clec'h C; Mayaux J; Lejeune J; Chevret S
JAMA; 2010 Jan; 303(4):341-8. PubMed ID: 20103758
[TBL] [Abstract][Full Text] [Related]
15. Hydrocortisone plus Fludrocortisone for Adults with Septic Shock.
Annane D; Renault A; Brun-Buisson C; Megarbane B; Quenot JP; Siami S; Cariou A; Forceville X; Schwebel C; Martin C; Timsit JF; Misset B; Ali Benali M; Colin G; Souweine B; Asehnoune K; Mercier E; Chimot L; Charpentier C; François B; Boulain T; Petitpas F; Constantin JM; Dhonneur G; Baudin F; Combes A; Bohé J; Loriferne JF; Amathieu R; Cook F; Slama M; Leroy O; Capellier G; Dargent A; Hissem T; Maxime V; Bellissant E;
N Engl J Med; 2018 Mar; 378(9):809-818. PubMed ID: 29490185
[TBL] [Abstract][Full Text] [Related]
16. Hemofiltration does not influence early S-100B serum levels in septic shock patients receiving stress doses of hydrocortisone or placebo.
Mussack T; Briegel J; Schelling G; Jochum M
Eur J Med Res; 2005 Feb; 10(2):81-7. PubMed ID: 15817428
[TBL] [Abstract][Full Text] [Related]
17. In septic shock and CAP, hydrocortisone + fludrocortisone reduced 90-d mortality.
Maki DG
Ann Intern Med; 2024 Jun; 177(6):JC62. PubMed ID: 38830222
[TBL] [Abstract][Full Text] [Related]
18. Low-dose hydrocortisone improves shock reversal and reduces cytokine levels in early hyperdynamic septic shock.
Oppert M; Schindler R; Husung C; Offermann K; Gräf KJ; Boenisch O; Barckow D; Frei U; Eckardt KU
Crit Care Med; 2005 Nov; 33(11):2457-64. PubMed ID: 16276166
[TBL] [Abstract][Full Text] [Related]
19. Hydrocortisone therapy for patients with multiple trauma: the randomized controlled HYPOLYTE study.
Roquilly A; Mahe PJ; Seguin P; Guitton C; Floch H; Tellier AC; Merson L; Renard B; Malledant Y; Flet L; Sebille V; Volteau C; Masson D; Nguyen JM; Lejus C; Asehnoune K
JAMA; 2011 Mar; 305(12):1201-9. PubMed ID: 21427372
[TBL] [Abstract][Full Text] [Related]
20. Hemofiltrastion does not influence early S-100B serum levels in septic shock patients receiving stress doses of hydrocortisone or placebo.
Mussack T; Briegel J; Schelling G; Jochum M
Eur J Med Res; 2005 Jan; 10(1):11-7. PubMed ID: 15737948
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
